• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆液性积液中癌的检测:综述

Detection of carcinoma in serous effusions: a review.

作者信息

Li Min, Zhao Lanbo, Zhou Xue, Zhang Kailu, Yin Panyue, Liu Shuhua, Zou Yuliang, Li Qiling

机构信息

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061, China.

College of Chemistry Engineering, Tianjin University Tianjin 300350, China.

出版信息

Am J Cancer Res. 2021 Jan 1;11(1):43-60. eCollection 2021.

PMID:33520359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7840719/
Abstract

A malignant serous effusion is one of the most common complications of advanced tumors, indicating a poor prognosis and having a profound impact on diagnosis, treatment, and prognosis. It is of great significance to identify benign and malignant effusions quickly and accurately. Both cellular and non-cellular components in the effusion can be employed for detection, diagnostic methods are necessary to obtain a definite diagnosis and more relevant information such as tumor classification. In this review, we focus on the comparison of several widespread cytological preparation methods, enrichment technology of exfoliated cells, and present tests for serous effusions, mainly including routine and special stains, immunocytochemistry, electron microscopy, enzyme-linked immunosorbent assay, flow cytometry, and molecular analysis.

摘要

恶性浆液性积液是晚期肿瘤最常见的并发症之一,预示着预后不良,对诊断、治疗及预后有深远影响。快速准确地鉴别良性和恶性积液具有重要意义。积液中的细胞成分和非细胞成分均可用于检测,需要诊断方法来获得明确诊断及更多相关信息,如肿瘤分类。在本综述中,我们重点比较了几种广泛应用的细胞学制片方法、脱落细胞富集技术以及目前针对浆液性积液的检测方法,主要包括常规染色和特殊染色、免疫细胞化学、电子显微镜检查、酶联免疫吸附测定、流式细胞术及分子分析。

相似文献

1
Detection of carcinoma in serous effusions: a review.浆液性积液中癌的检测:综述
Am J Cancer Res. 2021 Jan 1;11(1):43-60. eCollection 2021.
2
Detection of carbonic anhydrase IX protein in the diagnosis of malignant pleural effusion by enzyme-linked immunosorbent assay and immunocytochemistry.酶联免疫吸附试验和免疫细胞化学法检测碳酸酐酶 IX 蛋白在恶性胸腔积液诊断中的应用。
Cancer Cytopathol. 2012 Aug 25;120(4):269-75. doi: 10.1002/cncy.21191. Epub 2012 Feb 24.
3
Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions.血管内皮生长因子-A、-C和-D的差异表达在恶性胸腔积液癌症患者诊断及预后中的应用
Oncol Lett. 2015 Aug;10(2):667-674. doi: 10.3892/ol.2015.3305. Epub 2015 Jun 2.
4
Serous effusions in malignant lymphomas: a review.恶性淋巴瘤中的浆液性积液:综述
Diagn Cytopathol. 2006 May;34(5):335-47. doi: 10.1002/dc.20432.
5
E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions.E-钙黏蛋白和钙视网膜蛋白作为免疫细胞化学标志物用于鉴别浆液性恶性积液与良性积液。
World J Gastroenterol. 2004 Aug 15;10(16):2406-8. doi: 10.3748/wjg.v10.i16.2406.
6
Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings.浆液性积液和腹腔灌洗的流式细胞免疫表型分析:与免疫细胞化学及形态学结果的比较
J Clin Pathol. 2000 Jul;53(7):513-7. doi: 10.1136/jcp.53.7.513.
7
Glucose transporter 1 protein detected by enzyme-linked immunosorbent assay and immunocytochemistry: a useful diagnostic tool for malignant pleural effusions.酶联免疫吸附试验和免疫细胞化学检测葡萄糖转运蛋白 1 蛋白:一种用于恶性胸腔积液的有用诊断工具。
Cancer Cytopathol. 2013 Dec;121(12):695-702. doi: 10.1002/cncy.21324. Epub 2013 Jul 16.
8
[Serous effusions].[浆液性积液]
Tidsskr Nor Laegeforen. 2000 Jan 30;120(3):367-72.
9
Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions.抗L523S抗体在良恶性浆液性积液诊断中的应用
Cancer. 2008 Feb 25;114(1):49-56. doi: 10.1002/cncr.23254.
10
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.胰岛素生长因子途径成员胰岛素样生长因子-II和胰岛素样生长因子结合蛋白-3在浆液性积液中的诊断和预后作用。
Hum Pathol. 2009 Apr;40(4):527-37. doi: 10.1016/j.humpath.2008.10.003. Epub 2009 Jan 3.

引用本文的文献

1
Plasmacytic Pleural Effusion as a Major Presentation of Angioimmunoblastic T-Cell Lymphoma: A Case Report.浆细胞性胸腔积液为血管免疫母细胞性 T 细胞淋巴瘤的主要表现之一:病例报告。
Curr Oncol. 2022 Oct 13;29(10):7637-7644. doi: 10.3390/curroncol29100603.
2
Diagnostic Value of Claudin-4 and EZH2 Immunohistochemistry in Effusion Cytology.Claudin-4 和 EZH2 免疫组织化学在胸水中的诊断价值。
Asian Pac J Cancer Prev. 2022 Aug 1;23(8):2779-2785. doi: 10.31557/APJCP.2022.23.8.2779.
3
Initial panel of immunocytochemical markers for identification of primary carcinoma site for effusions and peritoneal washings from women.用于鉴定女性胸腔积液和腹腔灌洗中原发癌部位的初始免疫细胞化学标志物组。
Int J Clin Exp Pathol. 2022 Apr 15;15(4):191-200. eCollection 2022.
4
Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.可溶性程序性细胞死亡受体 1(sPD-1)和可溶性程序性细胞死亡配体 1(sPD-L1)对肝细胞癌的预后价值:系统评价和荟萃分析。
Cancer Immunol Immunother. 2022 Jul;71(7):1633-1644. doi: 10.1007/s00262-021-03103-2. Epub 2021 Nov 8.

本文引用的文献

1
A single-cell landscape of high-grade serous ovarian cancer.高级别浆液性卵巢癌的单细胞图谱。
Nat Med. 2020 Aug;26(8):1271-1279. doi: 10.1038/s41591-020-0926-0. Epub 2020 Jun 22.
2
Molecular testing on serous effusions.浆膜腔积液的分子检测。
Diagn Cytopathol. 2021 May;49(5):640-646. doi: 10.1002/dc.24392. Epub 2020 Feb 5.
3
Organoid of ovarian cancer: genomic analysis and drug screening.卵巢癌类器官:基因组分析与药物筛选。
Clin Transl Oncol. 2020 Aug;22(8):1240-1251. doi: 10.1007/s12094-019-02276-8. Epub 2020 Jan 14.
4
Patient-derived explants, xenografts and organoids: 3-dimensional patient-relevant pre-clinical models in endometrial cancer.患者来源的外植体、异种移植物和类器官:子宫内膜癌的 3 维患者相关临床前模型。
Gynecol Oncol. 2020 Jan;156(1):251-259. doi: 10.1016/j.ygyno.2019.11.020. Epub 2019 Nov 22.
5
Xenografts Derived From Patients' Ascites Recapitulate the Gemcitabine Resistance Observed in Pancreatic Cancer Patients.源自患者腹水的异种移植瘤重现了胰腺癌患者中观察到的吉西他滨耐药性。
Pancreas. 2019 Nov/Dec;48(10):1294-1302. doi: 10.1097/MPA.0000000000001438.
6
Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions.触珠蛋白和可溶性CD163检测在结核性与恶性胸腔积液鉴别诊断中的临床价值
Medicine (Baltimore). 2019 Oct;98(42):e17416. doi: 10.1097/MD.0000000000017416.
7
Modified Liquid-Based Cytology Technique for Immunocytochemistry in Effusion Specimen.用于积液标本免疫细胞化学的改良液基细胞学技术
Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2611-2617. doi: 10.31557/APJCP.2019.20.9.2611.
8
Anti-EpCAM antibodies for detection of metastatic carcinoma in effusions and peritoneal wash.用于检测积液和腹腔灌洗中转移性癌的抗上皮细胞粘附分子(EpCAM)抗体。
Oncol Lett. 2019 Aug;18(2):2019-2024. doi: 10.3892/ol.2019.10468. Epub 2019 Jun 12.
9
Current Status of Patient-Derived Ovarian Cancer Models.患者来源的卵巢癌模型的现状。
Cells. 2019 May 25;8(5):505. doi: 10.3390/cells8050505.
10
Next-Generation Sequencing and Emerging Technologies.下一代测序技术与新兴技术
Semin Thromb Hemost. 2019 Oct;45(7):661-673. doi: 10.1055/s-0039-1688446. Epub 2019 May 16.